By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Two Blades Foundation has granted Syngenta access to its genome engineering technology for commercial uses in certain crop plants under an agreement announced late on Tuesday.

The non-exclusive license provides Syngenta access to the Transcription Activator Like (TAL) effector Code, a technology for engineering proteins that bind to specific DNA sequences for precise modulation of genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.